Amnon Z. Abramowitz, M.D.,     Section on Intermediary Metabolism, Laboratory of Biomedical Sciences, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20014

George K. Aghajanian, M.D.,     Departments of Psychiatry and Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06519

Michael Aldrich, B.A.,     Department of Psychiatry, The University of Chicago, Chicago, Illinois 60637

Spyridon G.A. Alivisatos, M.D., Ph.D.,     Department of Biochemistry, The Chicago Medical School, Chicago, Illinois 60612

Arnold E. Andersen, M.D.,     Section on Intermediary Metabolism, Laboratory of Biomedical Sciences, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20014

Colin Atack, B. Sc.,     Department of Pharmacology, University of Göteborg, Medicinaregatan 7, Fack S-400, 33 Götebórg, Sweden

Julius Axelrod, Ph.D.,     Pharmacology Section, Laboratory of Clinical Sciences, National Institute of Mental Health, Bethesda, Maryland 20014

Max Baker, M.D.,     Section on Psychiatry, Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland 20014

Jack Barchas, M.D.,     Department of Psychiatry, Stanford University School of Medicine, Stanford, California 94305

Hans G. Baumgarten and Priv. -Doz., Dr. med.,     Department of Neuroanatomy, University of Hamburg, U.K.E., 2 Hamburg 20, Martinstr. 52, West Germany

Richard E. Bensinger, M.D.,     National Eye Institute, National Institutes of Health, Bethesda, Maryland 20014

Phil A. Berger, M.D.,     Department of Psychiatry, Stanford University School of Medicine, Stanford, California 94305

Barry Berkowitz, Ph.D.,     Pharmacology Section, Department of Physiologic Chemistry, Roche Institute of Molecular Biology, Nutley, New Jersey 07110

Gerrit H. Besselaar, M.D., Ph.D.,     Department of Clinical Pharmacology, Merck, Sharp & Dohme, Rahway, New Jersey 07066

Eugene L. Bliss, M.D.,     Department of Psychiatry, University of Utah Medical Center, Salt Lake City, Utah 84112

Floyd E. Bloom, M.D.,     Laboratory of Neuropharmacology, Division of Special Mental Health Research, National Institute of Mental Health, St. Elizabeths Hospital, Washington, D. C. 20032

R. Charles Boelkins, Ph.D.,     Department of Psychiatry, Stanford University School of Medicine, Stanford, California 94305

William O. Boggan, Ph.D.,     Department of Psychiatry, The University of Chicago, Chicago, Illinois 60637

H. Keith H. Brodie, M.D.,     Department of Psychiatry, Stanford University School of Medicine, Stanford, California 94305

William E. Bunney, Jr., M.D.,     Section on Psychiatry, Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland 20014

John S. Carman, M.D.,     Department of Psychiatry, The University of North Carolina School of Medicine, Chapel Hill, North Carolina 27514

Bernard J. Carroll, M.B., Ph.D.*,     Department of Psychiatry, University of Melbourne, Victoria, Australia

Robert L. Conner, Ph.D.,     Department of Psychology, Bowling Green State University, Bowling Green, Ohio 43403

Alec Coppen, M.D.,     Medical Research Council Laboratories, Neuropsychiatric Research Unit, Clinical Investigation Ward, Greenbank, West Park Hospital, Epsom, Surrey, England

Annica Dahlström, M.D., Ph.D.,     Institute of Neurobiology, University of Göteborg, Medicinaregatan 5, Fack S-400, 33 Göteborg, Sweden

Takeo Deguchi, M.D., Ph.D.,†,     Department of Psychiatry, Kyoto University, Kyoto, Japan

William C. Dement, M.D., Ph.D.,     Department of Psychiatry, Stanford University School of Medicine, Stanford, California 94305

Jefferson DoAmaral, Ph.D.,     Department of Psychiatry, Stanford University School of Medicine, Stanford, California 94305

Jerome A. Dominic, Ph.D.,     Department of Pharmacology, University of Kentucky College of Medicine, Lexington, Kentucky 40506

Mary K. Fairbanks,     Neuropsychology Research, Veterans Administration Hospital, Sepulveda, California 91343

James Ferguson, M.D.,     Department of Psychiatry, Stanford University School of Medicine, Stanford, California 94305

John D. Fernstrom, Ph.D.,     Department of Nutrition and Food Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139

Daniel X. Freedman, M.D.,     Department of Psychiatry, The University of Chicago, Chicago, Illinois 60637

E. Martin Gál, Ph.D., M.D.,     Department of Psychiatry, College of Medicine, University of Iowa, Iowa City, Iowa 52240

Marc Galanter, M.D.,     Laboratory of Clinical Psychopharmacology, Division of Special Mental Health Research, IRP, National Institute of Mental Health, Washington, D. C. 20032

Ralph Gauen, B.S.,     Illinois State Psychiatric Institute, Chicago, Illinois 60612

Frederick K. Goodwin, M.D.,     Clinical Research Unit, Section on Psychiatry, Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland 20014

David G. Grahame-Smith, Ph.D.,     Medical Research Council Unit and Department of Clinical Pharmacology, c/o Nuffield Department of Medicine, Radcliffe Infirmary, Oxford, OX2 6HE, England

Richard Green, M.A.,     Laboratory of Clinical Psychopharmacology, Division of Special Mental Health Research, IRP, National Institute of Mental Health, Washington, D.C. 20032

Christian Guilleminault, M.D.,     Department of Psychiatry and Neurology, Stanford University School of Medicine, Stanford, California 94305

Gordon Guroff, Ph.D.,     Section on Intermediary Metabolism, Laboratory of Biomedical Sciences, National Institute of Child Health and Human Development, Bethesda, Maryland 20014

Jan Häggendal, M.D., Ph.D.,     Department of Pharmacology, University of Göteborg, Medicinaregatan 7, Fack S-400, 33 Göteborg, Sweden

H.J. Haigler, Ph.D.,     Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519

Colin D. Hall, M.B., Ch.B.,     Department of Neurology, The University of North Carolina School of Medicine, Chapel Hill, North Carolina...